| Advances in ophthalmic drug delivery PWJ Morrison, VV Khutoryanskiy Therapeutic delivery 5 (12), 1297-1315, 2014 | 201 | 2014 |
| Penetration enhancers in ocular drug delivery RV Moiseev, PWJ Morrison, F Steele, VV Khutoryanskiy Pharmaceutics 11 (7), 321, 2019 | 164 | 2019 |
| Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability PWJ Morrison, CJ Connon, VV Khutoryanskiy Molecular Pharmaceutics 10 (2), 756-762, 2013 | 157 | 2013 |
| On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein EA Mun, PWJ Morrison, AC Williams, VV Khutoryanskiy Molecular pharmaceutics 11 (10), 3556-3564, 2014 | 138 | 2014 |
| Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase P Morrison, K Takishima, MR Rosner Journal of Biological Chemistry 268 (21), 15536-15543, 1993 | 110 | 1993 |
| Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases M Sakagami, P Morrison, WJ Welch Cell stress & chaperones 4 (1), 19-28, 1999 | 93 | 1999 |
| Mucoadhesive materials and drug delivery systems VV Khutoryanskiy John Wiley & Sons, 2014 | 66 | 2014 |
| Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C P Morrison, AR Saltiel, MR Rosner Journal of Biological Chemistry 271 (22), 12891-12896, 1996 | 66 | 1996 |
| Enhancement in corneal permeability of riboflavin using calcium sequestering compounds PWJ Morrison, VV Khutoryanskiy International Journal of Pharmaceutics 472 (1-2), 56-64, 2014 | 65 | 2014 |
| Hydrogen‐Bonded Complexes and Blends of Poly (acrylic acid) and Methylcellulose: Nanoparticles and Mucoadhesive Films for Ocular Delivery of Riboflavin OV Khutoryanskaya, PWJ Morrison, SK Seilkhanov, MN Mussin, ... Macromolecular bioscience 14 (2), 225-234, 2014 | 59 | 2014 |
| Crown ethers: novel permeability enhancers for ocular drug delivery? PWJ Morrison, NN Porfiryeva, S Chahal, IA Salakhov, C Lacourt, ... Molecular Pharmaceutics 14 (10), 3528-3538, 2017 | 55 | 2017 |
| In vitro topical delivery of chlorhexidine to the cornea: Enhancement using drug-loaded contact lenses and β-cyclodextrin complexation, and the importance of simulating tear … MG Hewitt, PWJ Morrison, HM Boostrom, SR Morgan, M Fallon, PN Lewis, ... Molecular Pharmaceutics 17 (4), 1428-1441, 2020 | 27 | 2020 |
| Mutation of Di-leucine residues in the juxtamembrane region alters EGF receptor expression P Morrison, KC Chung, MR Rosner Biochemistry 35 (46), 14618-14624, 1996 | 22 | 1996 |
| Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis SR Morgan, N Pilia, M Hewitt, RL Moses, R Moseley, PN Lewis, ... International journal of pharmaceutics 579, 119102, 2020 | 16 | 2020 |
| Anatomy of the eye and the role of ocular mucosa in drug delivery PWJ Morrison, VV Khutoryanskiy Mucoadhesive Materials and Drug Delivery Systems, 39-60, 2014 | 10 | 2014 |
| The Liberalisation of Trade in Financial Services and the General Agreement on Trade in Services P Morrison Sing. J. Int'l & Comp. L. 5, 593, 2001 | 2 | 2001 |
| Controlled Drug Delivery via the Ocular Route PWJ Morrison, VV Khutoryanskiy Fundamentals of Drug Delivery, 349-375, 2021 | | 2021 |
| Improving Riboflavin Delivery Into the Cornea for the Treatment of Keratoconus PWJ Morrison University of Reading, Reading School of Pharmacy (School of Chemistry, Food …, 2014 | | 2014 |
| HSP90 binding drugs, herbimycin A and geldanamycin, interfere with the maturation of growth factor receptor tyrosine kinases M Sakagami, P Morrison, W Welch FASEB JOURNAL 11 (9), A929-A929, 1997 | | 1997 |
| Regulation of Epidermal Growth Factor Receptor Through Threonine 669 and the Juxtamembrane Domain P Morrison University of Chicago, Department of Molecular Genetics and Cell Biology, 1996 | | 1996 |
